tiprankstipranks
Cerus Corporation (CH:CU2)
NASDAQ:CU2
Switzerland Market
CU2
Cerus
RESEARCH TOOLSreports

Cerus (CU2) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

CU2 Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Cerus
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CU2 Stock 12 Month Forecast

Average Price Target

―
Based on 1 Wall Street analysts offering 12 month price targets for Cerus in the last 3 months. The average price target is $4.04 with a high forecast of $4.04 and a low forecast of $4.04. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$4.04Average Price Target$4.04Lowest Price Target$4.04
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on CH:CU2
Josh Jennings
TD Cowen
TD Cowen
CHF4.04
Buy
―
Reiterated
07/31/26
Cerus (CERS): Strong 2Q26 Results, Upgraded Full‑Year Guidance and INTERCEPT Momentum Underpin Buy Rating
Craig-Hallum Analyst forecast on CH:CU2
William Bonello
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
05/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
BTIG Analyst forecast on CH:CU2
Mark Massaro
BTIG
BTIG
CHF3.23
Buy
―
Upgraded
05/01/26
Cerus upgraded to Buy from Neutral at BTIGCerus upgraded to Buy from Neutral at BTIG
Cantor Fitzgerald Analyst forecast on CH:CU2
Ross Osborn
Cantor Fitzgerald
Cantor Fitzgerald
CHF3.23
Buy
―
Reiterated
11/07/25
Cantor Fitzgerald Keeps Their Buy Rating on Cerus (CERS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on CH:CU2
Josh Jennings
TD Cowen
TD Cowen
CHF4.04
Buy
―
Reiterated
07/31/26
Cerus (CERS): Strong 2Q26 Results, Upgraded Full‑Year Guidance and INTERCEPT Momentum Underpin Buy Rating
Craig-Hallum Analyst forecast on CH:CU2
William Bonello
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
05/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
BTIG Analyst forecast on CH:CU2
Mark Massaro
BTIG
BTIG
CHF3.23
Buy
―
Upgraded
05/01/26
Cerus upgraded to Buy from Neutral at BTIGCerus upgraded to Buy from Neutral at BTIG
Cantor Fitzgerald Analyst forecast on CH:CU2
Ross Osborn
Cantor Fitzgerald
Cantor Fitzgerald
CHF3.23
Buy
―
Reiterated
11/07/25
Cantor Fitzgerald Keeps Their Buy Rating on Cerus (CERS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cerus

3 Months
William BonelloCraig-Hallum
Success Rate
7/12 ratings generated profit
58%
Average Return
+5.88%
Copying William Bonello's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +5.88% per trade.
1 Year
Josh JenningsTD Cowen
Success Rate
12/18 ratings generated profit
67%
Average Return
+36.98%
Copying Josh Jennings's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +36.98% per trade.
2 Years
William BonelloCraig-Hallum
Success Rate
12/12 ratings generated profit
100%
Average Return
+55.60%
Copying William Bonello's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +55.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CU2 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
3
4
2
2
1
Buy
1
3
2
2
0
Hold
2
2
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
9
4
4
1
In the current month, CU2 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CU2 average Analyst price target in the past 3 months is 4.04.
Each month's total comprises the sum of three months' worth of ratings.

CU2 Financial Forecast

CU2 Earnings Forecast

Next quarter’s earnings estimate for CU2 is >-$0.01 with a range of >-$0.01 to >-$0.01. The previous quarter’s EPS was >-$0.01. CU2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 45.99% of the time in the same period. In the last calendar year CU2 has Performed in-line its overall industry.
Next quarter’s earnings estimate for CU2 is >-$0.01 with a range of >-$0.01 to >-$0.01. The previous quarter’s EPS was >-$0.01. CU2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 45.99% of the time in the same period. In the last calendar year CU2 has Performed in-line its overall industry.

CU2 Sales Forecast

Next quarter’s sales forecast for CU2 is $51.49M with a range of $50.31M to $52.16M. The previous quarter’s sales results were $46.46M. CU2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 29.50% of the time in the same period. In the last calendar year CU2 has Performed in-line its overall industry.
Next quarter’s sales forecast for CU2 is $51.49M with a range of $50.31M to $52.16M. The previous quarter’s sales results were $46.46M. CU2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 29.50% of the time in the same period. In the last calendar year CU2 has Performed in-line its overall industry.

CU2 Stock Forecast FAQ

What is CH:CU2’s average 12-month price target, according to analysts?
Based on analyst ratings, Cerus Corporation’s 12-month average price target is 4.04.
    What is CH:CU2’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CU2, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cerus Corporation a Buy, Sell or Hold?
        Cerus Corporation has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Cerus Corporation’s share price target?
          The average share price target for Cerus Corporation is 4.04. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $4.04 ,and the lowest forecast is $4.04. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Cerus Corporation?
            Cerus Corporation’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
              How can I buy shares of Cerus Corporation?
              To buy shares of CH:CU2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.